Very early researchEnded earlyNCT01765803
What this trial is testing
Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells
Who this might be right for
Healthy Subjects
New Mexico Cancer Research Alliance 6
Showing 20 of 0 results